| Fund Name | CannaFi Fund PCC Domicile Gibraltar |
| Fund Description | A closed ended EIF (Experienced Investor Fund) structured as a PCC (Protected Cell Company) |
| Investment Director | CannaFi Group Ltd |
| First Cell Target Fund Size | £50million |
| Investment Objectives | Long term capital growth by investing in legal cannabis companies found in developing markets |
| Investment Size | Series A & B rounds £1m - £5m average investment per private company. 50% reserved for follow-on financing rounds |
| Investments | 20 total fund investments, no ore than 15 investments per continent and 5 investments per country |
| Product Categories | Medical, pharmaceutical, wellness edibles/beverages, supplements & cosmetics. Drug discovery, nootropics, CBD and clinics |
| Hurdle rate | 7% per annum |
| Expected Returns | 30% gross IRR |
| Minimum Investment | £50,000 |
| Investment Period | Maximum 5 years |
| Term | 5 years |
| GP Performance Fee | 20% after return of contributed capital |
| Management Fee | 2% per annum |
| Organizational Expenses | Not to exceed 2% |
